vs

Side-by-side financial comparison of MetLife (MET) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

MetLife is the larger business by last-quarter revenue ($600.0M vs $568.5M, roughly 1.1× Real Brokerage Inc). MetLife runs the higher net margin — 134.8% vs -0.1%, a 134.9% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 7.9%).

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

MET vs REAX — Head-to-Head

Bigger by revenue
MET
MET
1.1× larger
MET
$600.0M
$568.5M
REAX
Growing faster (revenue YoY)
REAX
REAX
+44.7% gap
REAX
52.6%
7.9%
MET
Higher net margin
MET
MET
134.9% more per $
MET
134.8%
-0.1%
REAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MET
MET
REAX
REAX
Revenue
$600.0M
$568.5M
Net Profit
$809.0M
$-447.0K
Gross Margin
7.9%
Operating Margin
-0.1%
Net Margin
134.8%
-0.1%
Revenue YoY
7.9%
52.6%
Net Profit YoY
-36.3%
82.7%
EPS (diluted)
$1.18
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MET
MET
REAX
REAX
Q4 25
$600.0M
Q3 25
$621.0M
$568.5M
Q2 25
$604.0M
$540.7M
Q1 25
$611.0M
$354.0M
Q4 24
$556.0M
Q3 24
$554.0M
$372.5M
Q2 24
$558.0M
Q1 24
$577.0M
$200.7M
Net Profit
MET
MET
REAX
REAX
Q4 25
$809.0M
Q3 25
$896.0M
$-447.0K
Q2 25
$729.0M
$1.5M
Q1 25
$945.0M
$-5.0M
Q4 24
$1.3B
Q3 24
$1.3B
$-2.6M
Q2 24
$946.0M
Q1 24
$867.0M
$-16.1M
Gross Margin
MET
MET
REAX
REAX
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Q1 24
10.3%
Operating Margin
MET
MET
REAX
REAX
Q4 25
Q3 25
-0.1%
Q2 25
0.3%
Q1 25
-1.5%
Q4 24
Q3 24
-0.7%
Q2 24
Q1 24
-7.8%
Net Margin
MET
MET
REAX
REAX
Q4 25
134.8%
Q3 25
144.3%
-0.1%
Q2 25
120.7%
0.3%
Q1 25
154.7%
-1.4%
Q4 24
228.6%
Q3 24
242.2%
-0.7%
Q2 24
169.5%
Q1 24
150.3%
-8.0%
EPS (diluted)
MET
MET
REAX
REAX
Q4 25
$1.18
Q3 25
$1.22
$0.00
Q2 25
$1.03
$0.01
Q1 25
$1.28
$-0.02
Q4 24
$1.75
Q3 24
$1.81
$-0.01
Q2 24
$1.28
Q1 24
$1.10
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MET
MET
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$25.6B
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$28.4B
$53.6M
Total Assets
$745.2B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MET
MET
REAX
REAX
Q4 25
$25.6B
Q3 25
$26.2B
$38.7M
Q2 25
$27.5B
$49.7M
Q1 25
$26.9B
$24.7M
Q4 24
$25.2B
Q3 24
$26.4B
$22.6M
Q2 24
$24.6B
Q1 24
$24.7B
$20.1M
Stockholders' Equity
MET
MET
REAX
REAX
Q4 25
$28.4B
Q3 25
$28.9B
$53.6M
Q2 25
$27.7B
$49.2M
Q1 25
$27.5B
$32.8M
Q4 24
$27.4B
Q3 24
$30.9B
$29.8M
Q2 24
$27.3B
Q1 24
$28.5B
$25.6M
Total Assets
MET
MET
REAX
REAX
Q4 25
$745.2B
Q3 25
$719.7B
$145.2M
Q2 25
$702.5B
$149.4M
Q1 25
$688.3B
$100.5M
Q4 24
$677.5B
Q3 24
$705.0B
$102.5M
Q2 24
$675.7B
Q1 24
$677.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MET
MET
REAX
REAX
Operating Cash FlowLast quarter
$7.1B
$8.8M
Free Cash FlowOCF − Capex
$8.4M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
8.75×
TTM Free Cash FlowTrailing 4 quarters
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MET
MET
REAX
REAX
Q4 25
$7.1B
Q3 25
$3.6B
$8.8M
Q2 25
$2.2B
$41.0M
Q1 25
$4.3B
$15.9M
Q4 24
$4.6B
Q3 24
$4.2B
$7.2M
Q2 24
$3.5B
Q1 24
$2.3B
$21.5M
Free Cash Flow
MET
MET
REAX
REAX
Q4 25
Q3 25
$8.4M
Q2 25
$40.8M
Q1 25
$15.7M
Q4 24
Q3 24
$6.8M
Q2 24
Q1 24
$21.4M
FCF Margin
MET
MET
REAX
REAX
Q4 25
Q3 25
1.5%
Q2 25
7.5%
Q1 25
4.4%
Q4 24
Q3 24
1.8%
Q2 24
Q1 24
10.7%
Capex Intensity
MET
MET
REAX
REAX
Q4 25
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
Q3 24
0.1%
Q2 24
Q1 24
0.0%
Cash Conversion
MET
MET
REAX
REAX
Q4 25
8.75×
Q3 25
3.98×
Q2 25
3.00×
27.13×
Q1 25
4.51×
Q4 24
3.63×
Q3 24
3.11×
Q2 24
3.69×
Q1 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MET
MET

Other$165.0M28%
Prepaidlegalplansandadministrativeonlycontracts$158.0M26%
Vision Fee For Service Arrangements$140.0M23%
Administrative Service$76.0M13%
Distribution Service$36.0M6%
Feebasedinvestmentmanagementservices$25.0M4%

REAX
REAX

Segment breakdown not available.

Related Comparisons